Article Chanwuyi Lifestyle Medicine Program Alleviates Immunological Deviation and Improves Behaviors in Autism Agnes S. Chan 1,2,*, Yvonne M. Y. Han 3, Sophia L. Sze 1,2, Chun-kwok Wong 4 , Ida M. T. Chu 4 and Mei-chun Cheung 5 1 Neuropsychology Laboratory, Department of Psychology, The Chinese University of Hong Kong, Hong Kong, China;
[email protected] 2 Research Center for Neuropsychological Well-Being, The Chinese University of Hong Kong, Hong Kong, China 3 Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong, China;
[email protected] 4 Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China;
[email protected] (C.-k.W.);
[email protected] (I.M.T.C.) 5 Department of Social Work, The Chinese University of Hong Kong, Hong Kong, China;
[email protected] * Correspondence:
[email protected]; Tel.: +852-394-366-54 Abstract: Given the association between deviated inflammatory chemokines, the pathogenesis of autism spectrum disorders (ASD), and our previous findings of the Chanwuyi Lifestyle Medicine Program regarding improved cognitive and behavioral problems in ASD, the present study aims to explore if this intervention can alter pro-inflammatory chemokines concentration. Thirty-two boys with ASD were assigned to the experimental group receiving the Chanwuyi Lifestyle Medicine Program for 7 months or the control group without a change in their lifestyle. The experimental group, Citation: Chan, A.S.; Han, Y.M.Y.; Sze, S.L.; Wong, C.-k.; Chu, I.M.T.; but not the control group, demonstrated significantly reduced CCL2 and CXCL8, a trend of reduction Cheung, M.-c.